EP2644614A3 - Solid state forms of 5-azacytidine and processes for preparation thereof - Google Patents

Solid state forms of 5-azacytidine and processes for preparation thereof Download PDF

Info

Publication number
EP2644614A3
EP2644614A3 EP13157868.4A EP13157868A EP2644614A3 EP 2644614 A3 EP2644614 A3 EP 2644614A3 EP 13157868 A EP13157868 A EP 13157868A EP 2644614 A3 EP2644614 A3 EP 2644614A3
Authority
EP
European Patent Office
Prior art keywords
preparation
azacytidine
processes
solid state
state forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13157868.4A
Other languages
German (de)
French (fr)
Other versions
EP2644614A2 (en
Inventor
Alexandr Jegorov
Ales Gavenda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ivax Pharmaceuticals sro
Original Assignee
Ivax Pharmaceuticals sro
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39272400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP2644614(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ivax Pharmaceuticals sro filed Critical Ivax Pharmaceuticals sro
Publication of EP2644614A2 publication Critical patent/EP2644614A2/en
Publication of EP2644614A3 publication Critical patent/EP2644614A3/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

The present invention provides novel crystalline forms of 5-deazacytidine, and pharmaceutical compositions comprising these novel forms. The invention also provides methods for the preparation of the novel forms and compositions.
EP13157868.4A 2007-01-11 2008-01-11 Solid state forms of 5-azacytidine and processes for preparation thereof Withdrawn EP2644614A3 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US88018207P 2007-01-11 2007-01-11
US88081007P 2007-01-16 2007-01-16
US93347407P 2007-06-05 2007-06-05
US99833807P 2007-10-09 2007-10-09
EP08705588A EP2118117A2 (en) 2007-01-11 2008-01-11 Solid state forms of 5-azacytidine and processes for preparation thereof

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP08705588A Division EP2118117A2 (en) 2007-01-11 2008-01-11 Solid state forms of 5-azacytidine and processes for preparation thereof
EP08705588.5 Division 2008-01-11

Publications (2)

Publication Number Publication Date
EP2644614A2 EP2644614A2 (en) 2013-10-02
EP2644614A3 true EP2644614A3 (en) 2014-02-26

Family

ID=39272400

Family Applications (2)

Application Number Title Priority Date Filing Date
EP13157868.4A Withdrawn EP2644614A3 (en) 2007-01-11 2008-01-11 Solid state forms of 5-azacytidine and processes for preparation thereof
EP08705588A Withdrawn EP2118117A2 (en) 2007-01-11 2008-01-11 Solid state forms of 5-azacytidine and processes for preparation thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP08705588A Withdrawn EP2118117A2 (en) 2007-01-11 2008-01-11 Solid state forms of 5-azacytidine and processes for preparation thereof

Country Status (3)

Country Link
US (1) US7759481B2 (en)
EP (2) EP2644614A3 (en)
WO (1) WO2008088779A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
BRPI0912717A2 (en) 2008-05-15 2014-12-23 Celgene Corp PHARMACEUTICAL COMPOSITION, AND, USE OF 5-AZACYTIDINE
ES2400779T3 (en) * 2008-08-06 2013-04-12 Sicor, Inc. Process to prepare an intermediate product of azacitidine
JP2014503597A (en) 2011-01-31 2014-02-13 セルジーン コーポレイション Pharmaceutical composition of cytidine analogue and method of use thereof
BR112013025167A2 (en) 2011-03-31 2019-09-24 Celgene Int Sarl process for preparing 5-azacitidine, or a salt, solvate, hydrate, or polymorph thereof, 5-azacitidine, 5-azacitidine salt, or a salt, solvate, hydrate, or polymorph
WO2014076616A2 (en) * 2012-11-19 2014-05-22 Shilpa Medicare Limited Formulations of 5-azacytidine
US9765108B2 (en) * 2012-11-19 2017-09-19 Shilpa Medicare Limited Formulation of 5-azacytidine
WO2014160698A1 (en) * 2013-03-26 2014-10-02 Celgene Corporation SOLID FORMS COMPRISING 4-AMINO-I-β-D-RIBOFURANOSYL-1,3,5-TRIAZIN-2(1H)-ONE AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF
CN109988207B (en) * 2017-12-29 2022-01-04 江苏豪森药业集团有限公司 Preparation method of azacitidine crystal form

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6028107A (en) * 1997-02-27 2000-02-22 Waugh; William Howard Orthomolecular medical use of L-citrulline for vasoprotection, relaxative smooth muscle tone and cell protection
GB2381451A (en) * 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
GB0225399D0 (en) 2002-10-31 2002-12-11 Merck Sharp & Dohme Therapeutic agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US6943249B2 (en) * 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US7078518B2 (en) * 2003-03-17 2006-07-18 Pharmion Corporation Forms of 5-Azacytidine
US20060247189A1 (en) * 2003-03-17 2006-11-02 Pharmion Corporation Forms of 5-Azacytidine

Also Published As

Publication number Publication date
EP2118117A2 (en) 2009-11-18
US20080287378A1 (en) 2008-11-20
EP2644614A2 (en) 2013-10-02
WO2008088779A3 (en) 2009-05-14
US7759481B2 (en) 2010-07-20
WO2008088779A2 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
EP2644614A3 (en) Solid state forms of 5-azacytidine and processes for preparation thereof
UA97502C2 (en) Crystalline solid basis of rasagilin
WO2008049116A3 (en) Substituted indoles
WO2006124748A3 (en) Multicyclic compounds and methods of their use
EP2305667A3 (en) Nilotinib intermediates and preparation thereof
ME02026B (en) New crystalline form V of agometaline, the process for its preparation and the pharmaceutical compositions containing it
WO2007127841A3 (en) Compositions and methods of preparation thereof
WO2006023627A8 (en) Rapamycin polymorph ii and uses thereof
ME02689B (en) New crystalline form iii of agometalin, the process for its preparation and pharmaceutical compositions containing it
EP2308870A3 (en) 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses
WO2009038683A3 (en) Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
SI1695709T1 (en) Crystalline form gamma-d of the chlorohydrate of ivabradine, process for its preparation and pharmaceutical compositions containing it
WO2007127292A3 (en) Tigeycline crystalline forms and processes for preparation thereof
WO2007044950A3 (en) Crystalline forms of docetaxel and processes for their preparation
EP2535058A3 (en) Stabilization of vaccines by lyophilization
WO2008057291A3 (en) Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof
WO2009042114A3 (en) Phenazine derivatives and uses thereof
WO2008027600A3 (en) Imatinib compositions
EP1637167A3 (en) New injectable formulations containing progesterone
WO2009094457A3 (en) Substituted benzhydrylethers
WO2009137714A3 (en) Forms of lapatinib ditosylate and processes for preparation thereof
WO2008154234A3 (en) Extended release formulation of nevirapine
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride
WO2008073863A3 (en) Preparation and utility of substituted allylamines
PL2231598T3 (en) Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 2118117

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 35/00 20060101ALI20140122BHEP

Ipc: A61K 31/706 20060101ALI20140122BHEP

Ipc: C07H 19/12 20060101AFI20140122BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140827